Phillip Parry, MD
Neurological Surgery · Marietta, GANPI 1770715559
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 89.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $24,119 and has fallen 63.8% since, to $8,740 in 2025.
Across 180 payments — averaging $423.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$68K
- Medtronic$7K
- Boston Scientific$308
- Irras USA, Inc.$156
- Kls-martin L.p.$152
- Biocomposites Inc$150
- plus $805 from 17 others
What the payments were for
- Consulting fees$38,02050%
- Speaking & faculty fees$21,65028%
- Travel & lodging$11,58815%
- Food & beverage$4,9366%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 131 | $67,956 |
| Medtronic(2 entities) | 18 | $6,666 |
| Boston Scientific | 3 | $308 |
| Irras USA, Inc. | 2 | $156 |
| Kls-martin L.p. | 2 | $152 |
| Biocomposites Inc | 1 | $150 |
| Intrinsic Therapeutics | 1 | $150 |
| Augmedics Inc. | 1 | $121 |
| Stryker | 1 | $98 |
| Abbott | 1 | $86 |
| Johnson & Johnson | 3 | $67 |
| Portola Pharmaceuticals, LLC | 3 | $63 |
| Chiesi USA, Inc. | 3 | $42 |
| Vertex | 1 | $28 |
| GSK | 1 | $26 |
| Stimwave Technologies Incorporated | 1 | $19 |
| Pfizer | 1 | $17 |
| Si-bone, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Spine Wave, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COALITION$24,742
- TLIF$12,640
- ExcelsiusGPS Robotic Navigation System$7,552
- MIDAS REX$5,742
- Art Spinal Disc$3,000
- XLIF$1,913
- CALIBER$1,025
- Excelsius - GPS$940
- Xvision$604
- HEDRON IC$348
- Pulse$305
- RISE-L$302
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$300
- INTELLIS ADAPTIVESTIM$264
- GENERAL PAIN MANAGEMENT$225
- ACP$171
- Bendini$162
- Excelsius3D Imaging System$161
- Stimulan$150
- CD HORIZON SPINAL SYSTEM$142
How this compares
$76,194 in reported general payments places this provider in the 85th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 101 | $1,116 |
| Gabapentin | 60 | $537 |
| Methocarbamol | 38 | $369 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $330 |
| Methylprednisolone | 51 | $289 |
| Oxycodone Hcl | 29 | $212 |
| Cyclobenzaprine Hcl | 32 | $212 |
| Ibuprofen | 22 | $148 |
| Ketorolac Tromethamine | 12 | $96 |
| Tizanidine Hcl | 37 | $82 |
| Meloxicam | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Marietta
- Said ElshihabiMarietta$409K
- Rishi GuptaMarietta$249K
- Franklin LinMarietta$69K
- Hilarie TomasiewiczMarietta$23K
- Tariq JavedMarietta$20K
- Regis HaidAtlanta$25.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.